George A. Skouras
Amministratore Delegato presso Cue Capital LP
Profilo
George A.
Skouras has founded Cue Capital LP in 2003, where he currently holds the title of Managing Director.
He is also currently working as a Director at Olatec Therapeutics LLC.
Posizioni attive di George A. Skouras
Società | Posizione | Inizio |
---|---|---|
Cue Capital LP
Cue Capital LP Investment ManagersFinance Cue Capital LP engages in the provision of strategic fund raising for fund management teams. It offers discovery meetings, due diligence, strategic consulting, and fundraising. The company was founded by George Skouras in 2003 and is headquartered in New York, NY. | Amministratore Delegato | 01/01/2003 |
Olatec Therapeutics LLC
Olatec Therapeutics LLC Pharmaceuticals: MajorHealth Technology Olatec Therapeutics LLC is a privately held biopharmaceutical company based in the United States. The American company is in the clinical stage of developing a platform of oral NLRP3 inhibitors to treat and prevent a broad spectrum of acute and chronic inflammatory diseases mediated by IL-1. Olatec's proprietary compounds include approximately 60 analogues being screened as viable drug candidates, and the company has over 140 patents granted covering its compounds. The company's drug development team is comprised of experienced management and international experts in translational medicine with unparalleled expertise in inflammation and immunology. Olatec is conducting clinical trials in the FDA and EMA. The company was founded by Damaris B. Skouras, who has been the CEO since incorporation. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Cue Capital LP
Cue Capital LP Investment ManagersFinance Cue Capital LP engages in the provision of strategic fund raising for fund management teams. It offers discovery meetings, due diligence, strategic consulting, and fundraising. The company was founded by George Skouras in 2003 and is headquartered in New York, NY. | Finance |
Olatec Therapeutics LLC
Olatec Therapeutics LLC Pharmaceuticals: MajorHealth Technology Olatec Therapeutics LLC is a privately held biopharmaceutical company based in the United States. The American company is in the clinical stage of developing a platform of oral NLRP3 inhibitors to treat and prevent a broad spectrum of acute and chronic inflammatory diseases mediated by IL-1. Olatec's proprietary compounds include approximately 60 analogues being screened as viable drug candidates, and the company has over 140 patents granted covering its compounds. The company's drug development team is comprised of experienced management and international experts in translational medicine with unparalleled expertise in inflammation and immunology. Olatec is conducting clinical trials in the FDA and EMA. The company was founded by Damaris B. Skouras, who has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- George A. Skouras